Mutual Of America Capital Management LLC Invitae Corp Transaction History

Mutual Of America Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $972,037 - $1.9 Million	-66,125 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$24.31 - $33.6 $23,191 - $32,054	-954 Reduced 1.42%	66,125 $1.88 Million
Q2 2021 Aug 06, 2021	SELL	$26.09 - $40.4 $916,202 - $1.42 Million	-35,117 Reduced 34.36%	67,079 $2.26 Million
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $1.15 Million - $1.97 Million	-34,648 Reduced 25.32%	102,196 $3.91 Million
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $477,327 - $700,911	-12,211 Reduced 8.19%	136,844 $5.72 Million

Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $729,058 - $1.15 Million	-25,644 Reduced 14.68%	149,055 $6.46 Million
Q2 2020 Aug 06, 2020	BUY	$11.71 - $30.29 $991,462 - $2.56 Million	84,668 Added 94.04%	174,699 $5.29 Million
Q1 2020 May 11, 2020	SELL	$7.64 - $27.5 $30,231 - $108,817	-3,957 Reduced 4.21%	90,031 $1.23 Million
Q4 2019 Feb 11, 2020	SELL	$15.02 - $20.57 $9,868 - $13,514	-657 Reduced 0.69%	93,988 $1.52 Million
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $1.78 Million - $2.6 Million	94,645 New	94,645 $1.82 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.